Accutane Labeling Revised To Include Psychiatric Disorder Brochure
Executive Summary
Labeling for Roche's Accutane has been revised to include a brochure for isotretinoin prescribers on recognizing and appropriately handling psychiatric disorders
You may also be interested in...
Roche Accutane Updated Labeling Includes Musculoskeletal AE Warning
Roche is updating Accutane labeling with a warning on potential musculoskeletal adverse effects, particularly in adolescents
Roche Accutane Updated Labeling Includes Musculoskeletal AE Warning
Roche is updating Accutane labeling with a warning on potential musculoskeletal adverse effects, particularly in adolescents
Roche Accutane Generic Forecast Assumes Hesitancy To Switch Risk Plans
Roche is projecting a relatively gentle generic erosion curve for Accutane based on the reluctance of patients and physicians to switch from the branded pregnancy risk management program, U.S. North America CEO George Abercrombie suggested